Atlas Trials

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Clinical trial NCT03087708 · TERMINATED

Trial details

NCT number
NCT03087708
Sponsor
Alliance for Clinical Trials in Oncology
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Stage IIIB Non-Small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Start date
2018-03-23
Primary completion
2021-01-04
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.